A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma von Martin, Thomas, Baz, Rachid, Benson, Don M., Lendvai, Nikoletta, Wolf, Jeffrey, Munster, Pamela, Lesokhin, Alexander M., Wack, Claudine, Charpentier, Eric, Campana, Frank, Vij, Ravi

Volltext

Nivolumab plus Ipilimumab in Advanced Melanoma von WOLCHOK, Jedd D, KLUGER, Harriet, BURKE, Matthew M, CALDWELL, Anne, KRONENBERG, Stephanie A, AGUNWAMBA, Blessing U, XIAOLING ZHANG, LOWY, Israel, INZUNZA, Hector David, FEELY, William, HORAK, Christine E, QUAN HONG, CALLAHAN, Margaret K, KORMAN, Alan J, WIGGINTON, Jon M, GUPTA, Ashok, SZNOL, Mario, POSTOW, Michael A, RIZVI, Naiyer A, LESOKHIN, Alexander M, SEGAL, Neil H, ARIYAN, Charlotte E, GORDON, Ruth-Ann, REED, Kathleen

Volltext

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel von Raje, Noopur, Anderson, Kenneth, Einsele, Hermann, Efebera, Yvonne, Gay, Francesca, Hammond, Sarah P., Lesokhin, Alexander M., Lonial, Sagar, Ludwig, Heinz, Moreau, Philippe, Patel, Krina, Ramasamy, Karthik, Mateos, Maria-Victoria

Volltext

Immunotherapy of Lymphoma and Myeloma: Facts and Hopes von Pianko, Matthew J, Moskowitz, Alison J, Lesokhin, Alexander M

Volltext

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma von Maclachlan, Kylee H., Rustad, Even H., Derkach, Andriy, Zheng-Lin, Binbin, Yellapantula, Venkata, Diamond, Benjamin, Hultcrantz, Malin, Ziccheddu, Bachisio, Boyle, Eileen M., Blaney, Patrick, Bolli, Niccolò, Zhang, Yanming, Dogan, Ahmet, Lesokhin, Alexander M., Morgan, Gareth J., Landgren, Ola, Maura, Francesco

Volltext

Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma von Lesokhin, Alexander M, Bal, Susan, Badros, Ashraf Z

Volltext

Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach von Pianko, Matthew J., Tiutan, Timothy, Derkach, Andriy, Flynn, Jessica, Salvatore, Steven P., Jaffer‐Sathick, Insara, Rossi, Adriana C., Lahoud, Oscar, Hultcrantz, Malin, Shah, Urvi A., Maclachlan, Kylee, Chung, David J., Shah, Gunjan L., Landau, Heather J., Korde, Neha, Mailankody, Sham, Lesokhin, Alexander M., Tan, Carlyn, Scordo, Michael, Jaimes, Edgar A., Giralt, Sergio A., Usmani, Saad, Hassoun, Hani

Volltext

Extreme body mass index and survival in newly diagnosed multiple myeloma patients von Shah, Urvi A., Whiting, Karissa, Devlin, Sean, Ershler, Rachel, Kanapuru, Bindu, Lee, David J., Tahri, Sabrin, Gwise, Thomas, Rustad, Even H., Mailankody, Sham, Lesokhin, Alexander M., Kazandjian, Dickran, Maura, Francesco, Auclair, Daniel, Birmann, Brenda M., Usmani, Saad Z., Gormley, Nicole, Marinac, Catherine R., Landgren, Ola

Volltext

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs von Nakahara, Takeshi, Uchi, Hiroshi, Lesokhin, Alexander M., Avogadri, Francesca, Rizzuto, Gabrielle A., Hirschhorn-Cymerman, Daniel, Panageas, Katherine S., Merghoub, Taha, Wolchok, Jedd D., Houghton, Alan N.

Volltext

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results von Lesokhin, Alexander M., Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Miles Prince, H., Niesvizky, Ruben, Rodrίguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Touzeau, Cyrille, Jethava, Yogesh, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Gabayan, Afshin Eli, Stevens, Don A., Nooka, Ajay K., Manier, Salomon, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Searle, Emma, Leip, Eric, Sullivan, Sharon T., Conte, Umberto, Elmeliegy, Mohamed, Czibere, Akos, Viqueira, Andrea, Mohty, Mohamad

Volltext

Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes von KITANO, Shigehisa, POSTOW, Michael A, ALTAN-BONNET, Gregoire, WOLCHOK, Jedd D, LESOKHIN, Alexander M, ZIEGLER, Carly G. K, KUK, Deborah, PANAGEAS, Katherine S, CORTEZ, Czrina, RASALAN, Teresa, ADAMOW, Mathew, JIANDA YUAN, WONG, Philip

Volltext

Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action von Wudhikarn, Kitsada, Wills, Beatriz, Lesokhin, Alexander M.

Volltext

Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies von Cohen, Adam D., Garfall, Alfred L., Dogan, Ahmet, Lacey, Simon F., Martin, Chris, Lendvai, Nikoletta, Vogl, Dan T., Spear, Matthew, Lesokhin, Alexander M.

Volltext

Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition von Pianko, Matthew J., Devlin, Sean M., Littmann, Eric R., Chansakul, Aisara, Mastey, Donna, Salcedo, Meghan, Fontana, Emily, Ling, Lilan, Tavitian, Elizabet, Slingerland, John B., Slingerland, Ann E., Clurman, Annelie, Gomes, Antonio L.C., Taur, Ying, Pamer, Eric G., Peled, Jonathan U., van den Brink, Marcel R.M., Landgren, Ola, Lesokhin, Alexander M.

Volltext

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma von Costa, Bruno Almeida, Flynn, Jessica, Nishimura, Noriko, Devlin, Sean M., Farzana, Tasmin, Rajeeve, Sridevi, Chung, David J., Landau, Heather J., Lahoud, Oscar B., Scordo, Michael, Shah, Gunjan L., Hassoun, Hani, Maclachlan, Kylee, Hultcrantz, Malin, Korde, Neha, Lesokhin, Alexander M., Shah, Urvi A., Tan, Carlyn R., Giralt, Sergio A., Usmani, Saad Z., Nath, Karthik, Mailankody, Sham

Volltext

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma von Nath, Karthik, Shekarkhand, Tala, Nemirovsky, David, Derkach, Andriy, Costa, Bruno Almeida, Nishimura, Noriko, Farzana, Tasmin, Rueda, Colin, Chung, David J., Landau, Heather J., Lahoud, Oscar B., Scordo, Michael, Shah, Gunjan L., Hassoun, Hani, Maclachlan, Kylee, Korde, Neha, Shah, Urvi A., Tan, Carlyn Rose, Hultcrantz, Malin, Giralt, Sergio A., Usmani, Saad Z., Shahid, Zainab, Mailankody, Sham, Lesokhin, Alexander M.

Volltext

Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases von Pak, Wai Lun Will, Brumwell, Natalie A., Kabel, Charlene C., Gutgarts, Victoria, Jaffer Sathick, Insara, Mailankody, Sham, Lesokhin, Alexander M., Landau, Heather J., Shaikh, Aisha

Volltext

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy von Naidoo, Jarushka, Wang, Xuan, Woo, Kaitlin M, Iyriboz, Tunc, Halpenny, Darragh, Cunningham, Jane, Chaft, Jamie E, Segal, Neil H, Callahan, Margaret K, Lesokhin, Alexander M, Rosenberg, Jonathan, Voss, Martin H, Rudin, Charles M, Rizvi, Hira, Hou, Xue, Rodriguez, Katherine, Albano, Melanie, Gordon, Ruth-Ann, Leduc, Charles, Rekhtman, Natasha, Harris, Bianca, Menzies, Alexander M, Guminski, Alexander D, Carlino, Matteo S, Kong, Benjamin Y, Wolchok, Jedd D, Postow, Michael A, Long, Georgina V, Hellmann, Matthew D

Volltext

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study von Lesokhin, Alexander M, Ansell, Stephen M, Armand, Philippe, Scott, Emma C, Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M, Cohen, Adam D, Schuster, Stephen J, Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H, Freeman, Gordon J, Rodig, Scott J, Cattry, Deepika, Zhu, Lili, Grosso, Joseph F, Bradley Garelik, M Brigid, Shipp, Margaret A, Borrello, Ivan, Timmerman, John

Volltext

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma von Ansell, Stephen M, Lesokhin, Alexander M, Borrello, Ivan, Halwani, Ahmad, Scott, Emma C, Gutierrez, Martin, Schuster, Stephen J, Millenson, Michael M, Cattry, Deepika, Freeman, Gordon J, Rodig, Scott J, Chapuy, Bjoern, Ligon, Azra H, Zhu, Lili, Grosso, Joseph F, Kim, Su Young, Timmerman, John M, Shipp, Margaret A, Armand, Philippe

Volltext